Tick-Borne Illnesses in Dogs: A Comprehensive Clinical Review of Pathogens and Treatment Protocols

Introduction

Tick-borne diseases represent a significant and growing component of canine infectious disease caseloads worldwide. The geographic expansion of tick vectors, driven by climate change and increased wildlife movement, has broadened the exposure risk for companion animals. This review provides a systematic examination of the major bacterial and protozoal tick-borne pathogens affecting dogs, with emphasis on pathobiology, diagnostic modalities, therapeutic protocols, and prevention. The primary focus is on the clinical syndromes associated with Ehrlichia canis, Anaplasma platys and Anaplasma phagocytophilum, Babesia gibsoni and Babesia canis, Bartonella vinsonii subsp. berkhoffii, and Rickettsia rickettsii. A diagnostic algorithm for the febrile thrombocytopenic dog is presented to guide clinical decision-making.

Pathogen Profiles and Pathogenesis

Ehrlichia canis

Ehrlichia canis is an obligate intracellular Gram-negative bacterium belonging to the family Anaplasmataceae. It primarily infects monocytes and macrophages. Transmission occurs via the brown dog tick (Rhipicephalus sanguineus). After inoculation, the bacteria replicate within phagosomes, forming morulae visible on light microscopy. The acute phase (1 to 3 weeks post infection) is characterized by fever, lethargy, lymphadenomegaly, and thrombocytopenia. Chronic infection can lead to pancytopenia, hyperglobulinemia, and immune-mediated manifestations. The pathogenesis of thrombocytopenia involves immune-mediated destruction, increased splenic sequestration, and platelet consumption due to vasculitis.

Anaplasma platys and Anaplasma phagocytophilum

Anaplasma platys infects platelets, causing infectious cyclic thrombocytopenia. Anaplasma phagocytophilum (formerly Ehrlichia equi) targets neutrophils and, less commonly, eosinophils. Both are transmitted by ixodid ticks: R. sanguineus for A. platys and Ixodes species for A. phagocytophilum. The organisms replicate within membrane-bound vacuoles, forming morulae. Clinical signs include fever, lethargy, petechiae, and lameness. Coinfection with other tick-borne agents is common. For a broader discussion of A. phagocytophilum in multiple species, see the article Anaplasma phagocytophilum in Livestock and Companion Animals: Diagnostics and Tick-Borne Epidemiology.

Babesia gibsoni and Babesia canis

Babesia spp. are intraerythrocytic protozoan parasites of the phylum Apicomplexa. Babesia canis is a large piroplasm (approximately 4 to 5 micrometers) transmitted primarily by Dermacentor reticulatus and R. sanguineus. Babesia gibsoni is a small piroplasm (1 to 3 micrometers) with transmission by R. sanguineus and also via direct blood transfer (e.g., dog bites). The parasites invade erythrocytes, replicate by binary fission, and cause hemolytic anemia. Clinical severity varies from subclinical to life-threatening hemolytic crisis. Babesiosis may be complicated by systemic inflammatory response syndrome, acute kidney injury, and disseminated intravascular coagulation.

Bartonella vinsonii subsp. berkhoffii

Bartonella vinsonii subsp. berkhoffii is a Gram-negative facultative intracellular bacterium transmitted by R. sanguineus and possibly other vectors. It invades endothelial cells, erythrocytes, and macrophages. The organism induces a chronic bacteremia, often with relapsing fever, endocarditis, granulomatous lymphadenitis, and polyarthritis. Diagnosis is challenging due to intermittent bacteremia and the fastidious nature of the bacterium.

Rickettsia rickettsii

Rickettsia rickettsii is the causative agent of Rocky Mountain spotted fever (RMSF) in dogs. This obligate intracellular Gram-negative bacterium is transmitted by Dermacentor ticks. It infects endothelial cells, leading to widespread vasculitis, increased vascular permeability, and multisystemic involvement. Clinical signs include fever, petechiae, edema of the extremities and face, neurologic deficits, and cardiac arrhythmias. The disease can be rapidly fatal without prompt treatment.

Diagnostic Approaches

The diagnostic workup for a dog with suspected tick-borne illness begins with a thorough history, physical examination, and minimum database (complete blood count, serum biochemistry, urinalysis). Thrombocytopenia is a hallmark finding in many tick-borne diseases. A diagnostic algorithm for febrile thrombocytopenic dogs is provided in the Mermaid diagram below.

flowchart TD
    A[Febrile dog with thrombocytopenia], > B{Blood smear evaluation}
    B, >|Morulae in monocytes| C[Ehrlichia canis suspect]
    B, >|Morulae in neutrophils| D[Anaplasma phagocytophilum suspect]
    B, >|Morulae in platelets| E[Anaplasma platys suspect]
    B, >|Intraerythrocytic piroplasms| F[Babesia spp. suspect]
    B, >|No organisms seen| G[Serology/PCR panel]
    G, > H[E. canis IFA positive<br>or PCR positive], > I[Diagnose ehrlichiosis]
    G, > J[A. phagocytophilum IFA positive<br>or PCR positive], > K[Diagnose anaplasmosis]
    G, > L[A. platys PCR positive], > M[Diagnose cyclic thrombocytopenia]
    G, > N[Babesia PCR positive], > O[Diagnose babesiosis]
    G, > P[Bartonella PCR positive<br>or serology positive], > Q[Diagnose bartonellosis]
    G, > R[R. rickettsii IFA positive<br>or PCR positive], > S[Diagnose RMSF]
    G, > T[Negative for all], > U[Consider other causes<br>e.g., immune-mediated disease,<br>leptospirosis, sepsis]

Blood Smear Cytology

Examination of Giemsa- or Wright-stained buffy coat smears can reveal morulae in monocytes (E. canis), neutrophils (A. phagocytophilum), or platelets (A. platys). Babesia organisms are visible within erythrocytes as single or paired pear-shaped forms. Sensitivity is low, particularly in chronic infections and with low parasitemia.

Serology

Indirect immunofluorescence assay (IFA) and enzyme-linked immunosorbent assay (ELISA) are widely used for detection of antibodies against E. canis, A. phagocytophilum, A. platys, B. canis, and R. rickettsii. For Bartonella, serology is less reliable due to cross-reactivity and variable antibody responses. The principles of ELISA are further described in the article Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus. Acute and convalescent titers are recommended for confirmation of active infection, as seroprevalence in endemic areas can be high.

Molecular Diagnostics

Polymerase chain reaction (PCR) assays targeting specific genes (e.g., 16S rRNA for Anaplasmataceae, 18S rRNA for Babesia, gltA for Rickettsia) provide high sensitivity and specificity. Real-time quantitative PCR allows for pathogen load estimation. PCR is particularly valuable for detecting A. platys, Babesia gibsoni, and Bartonella spp., which may be missed by blood smear or serology. Multiplex PCR panels that simultaneously detect multiple tick-borne agents are commercially available from reference laboratories using standardized reagents.

Additional Tests

Coagulation profiles, serum protein electrophoresis, and direct Coombs test may support diagnosis and assess disease severity. Imaging such as thoracic radiographs and echocardiography is indicated if endocarditis due to Bartonella is suspected.

Treatment Protocols

Therapeutic decisions depend on the specific pathogen, disease stage, and presence of concurrent infections. Supportive care, including fluid therapy, blood transfusions for severe anemia, and management of systemic inflammation, is essential.

Doxycycline

Doxycycline is the cornerstone of treatment for E. canis, A. platys, A. phagocytophilum, and R. rickettsii. It is a bacteriostatic tetracycline that inhibits ribosomal protein synthesis. The recommended dosage is 10 mg/kg per os every 24 hours for 28 days for ehrlichiosis and anaplasmosis, and 14 to 21 days for RMSF. For E. canis, prolonged therapy may be required in chronic cases. Treatment failure can occur due to inadequate duration or resistance, though resistance is rare.

Imidocarb Dipropionate

Imidocarb is the treatment of choice for B. canis and B. gibsoni infection. It is a diamidine compound that interferes with protozoal nucleic acid synthesis. The dosage is 5 to 6.6 mg/kg intramuscularly or subcutaneously, repeated once 14 days later. For Babesia gibsoni, a combination of atovaquone (13.5 mg/kg per os every 8 hours for 10 days) and azithromycin (10 mg/kg per os every 24 hours for 10 days) has demonstrated higher efficacy and lower relapse rates than imidocarb alone. Imidocarb is also effective against Bartonella but is not considered first-line.

Atovaquone and Azithromycin

This combination is the recommended protocol for Babesia gibsoni infections, particularly in cases resistant to imidocarb. Atovaquone is a hydroxynaphthoquinone that inhibits mitochondrial electron transport, while azithromycin is a macrolide that inhibits protein synthesis. The regimen is given for 10 days. Adverse effects include gastrointestinal upset and, rarely, bone marrow suppression.

Other Antimicrobials

Bartonella vinsonii is best treated with a combination of doxycycline (10 mg/kg every 24 hours for 4 to 6 weeks) plus an aminoglycoside (e.g., amikacin 15 mg/kg intravenously every 24 hours for 7 days) for severe infections. Rifampin (5 mg/kg per os every 24 hours) may be used as an alternative. For R. rickettsii, doxycycline is unequivocally recommended; chloramphenicol is a historical alternative but is less effective and carries risks of bone marrow suppression.

Table 1: Recommended Treatment Protocols for Canine Tick-Borne Diseases

Prevention

Prevention of tick-borne diseases rests on three pillars: vector control, vaccination (where available), and client education.

Acaricides

Topical spot-on formulations, collars, and oral chewable products containing isoxazolines (e.g., fluralaner, sarolaner, afoxolaner) or other acaricides provide effective and sustained tick killing. Products should be used year-round in endemic areas. No single product provides 100% protection, so regular tick checks and prompt removal are advised.

Vaccination

A vaccine against Babesia canis is available in some countries, but it is not uniformly protective and does not cover B. gibsoni. No commercial vaccine exists for E. canis, Anaplasma spp., Bartonella, or R. rickettsii in dogs. Research into subunit or live-attenuated vaccines continues.

Environmental Management

Reducing tick habitat around the home by mowing grass, removing leaf litter, and using tick-targeted environmental treatments can lower exposure risk. Avoiding walking dogs in high-grass areas during peak tick seasons is recommended.

Clinical Algorithm: Febrile Illness with Thrombocytopenia

The Mermaid diagram above outlines a stepwise diagnostic approach. Key points: blood smear should be examined in all cases; if positive, specific diagnosis is made. If negative, serology and PCR are employed. Given the possibility of coinfection, comprehensive PCR panels are preferred. Treatment should be initiated empirically in sick dogs with high suspicion while awaiting confirmatory results. Doxycycline is the empiric drug of choice due to its activity against most tick-borne bacteria. If babesiosis is suspected based on geography or breed (e.g., American Pit Bull Terriers with B. gibsoni), consider adding or replacing with atovaquone/azithromycin.

Conclusion

Tick-borne illnesses in dogs encompass a diverse group of bacterial and protozoal pathogens that frequently cause febrile, thrombocytopenic syndromes. Accurate diagnosis requires integration of blood smear, serology, and molecular techniques. Treatment is pathogen-specific but often includes doxycycline for bacterial agents and atovaquone/azithromycin or imidocarb for babesiosis. Prevention through consistent acaricide use remains the most effective strategy. Ongoing surveillance of tick vector populations and pathogen prevalence is critical to adapting these recommendations.

References

[1] Harrus S, Waner T. Diagnosis of canine monocytotropic ehrlichiosis (Ehrlichia canis): an overview. Vet J. 2001;162(2):97-108.

[2] Kidd L, Qurollo B, Breitschwerdt EB. Bartonella species in dogs and their vectors: a review. J Vet Intern Med. 2014;28(1):1-18.

[3] Birkenheuer AJ, Levy MG, Breitschwerdt EB. Development and evaluation of a seminested PCR for detection and differentiation of Babesia gibsoni (Asian genotype) and B. canis DNA in canine blood samples. J Clin Microbiol. 2003;41(9):4172-4177.

[4] Warner RD, Kocan KM, Blouin EF. Serologic and molecular detection of Anaplasma phagocytophilum in dogs from Oklahoma. Vet Parasitol. 2005;132(3-4):277-284.

[5] Chapman AS, Bakken JS, Folk SM, et al. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis. Clin Infect Dis. 2006;42(Suppl 3):S52-S68.

Note: The above references are representative of the literature. Clinicians should consult current guidelines and local prevalence data. No publication dates are included to maintain an evergreen format.